These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 5444984)

  • 1. [Biology and therapy of schizophrenia].
    Buscaino VM
    Acta Neurol (Napoli); 1970; 25(1):1-58. PubMed ID: 5444984
    [No Abstract]   [Full Text] [Related]  

  • 2. [Schizophrenia and cerebral amines].
    Véron JP; Kezirian S
    Presse Med (1893); 1971 Oct; 79(44):1973-4. PubMed ID: 5119550
    [No Abstract]   [Full Text] [Related]  

  • 3. [Neurobiology and treatment of mentalisation in schizophrenia].
    Herold R; Tényi T
    Neuropsychopharmacol Hung; 2005 Dec; 7(4):187-93. PubMed ID: 16496483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of some biochemical abnormalities in schizophrenia.
    Rodnight R
    Acta Neurol (Napoli); 1975; 30(1):85-101. PubMed ID: 1063539
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cerebral amines].
    Nihon Rinsho; 1976 Sep; 34(9):2746-62. PubMed ID: 11360
    [No Abstract]   [Full Text] [Related]  

  • 6. Alterations of serotonin transmission in schizophrenia.
    Abi-Dargham A
    Int Rev Neurobiol; 2007; 78():133-64. PubMed ID: 17349860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain monoamine changes in chronic paranoid schizophrenia and their possible relation to increased dopamine receptor sensitivity.
    Farley IJ; Shannak KS; Hornykiewicz O
    Adv Biochem Psychopharmacol; 1980; 21():427-33. PubMed ID: 6155058
    [No Abstract]   [Full Text] [Related]  

  • 8. Lewy body/alpha-synucleinopathy in schizophrenia and depression: a preliminary neuropathological study.
    Jellinger KA
    Acta Neuropathol; 2009 Apr; 117(4):423-7. PubMed ID: 19198857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excretion of indoleamines in schizophrenia.
    Bueno JR; Himwich HE
    Int J Neurol; 1967; 6(1):65-76. PubMed ID: 5622712
    [No Abstract]   [Full Text] [Related]  

  • 10. [New pharmacological approaches to the treatment of schizophrenia].
    Uzbay IT
    Turk Psikiyatri Derg; 2009; 20(2):175-82. PubMed ID: 19504368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of dysfunctional glutamatergic transmission for the development of psychotic symptoms.
    Pietraszek M
    Pol J Pharmacol; 2003; 55(2):133-54. PubMed ID: 12926541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Schizophrenia in clinical imaging; anomalies in brain anatomy and metabolism].
    Hulshoff Pol HE; Baaré WF; Mali WP; van Ree JM; Kahn RS
    Ned Tijdschr Geneeskd; 1995 Mar; 139(10):494-7. PubMed ID: 7891755
    [No Abstract]   [Full Text] [Related]  

  • 13. Alterations of dopamine and serotonin transmission in schizophrenia.
    Remington G
    Prog Brain Res; 2008; 172():117-40. PubMed ID: 18772030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schizophrenia: diverse approaches to a complex disease.
    Sawa A; Snyder SH
    Science; 2002 Apr; 296(5568):692-5. PubMed ID: 11976442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Microscopic changes in the brain in cases clinically diagnosed as schizophrenia].
    Papierz W
    Neuropatol Pol; 1970; 8(3):321-8. PubMed ID: 5453721
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pathologic anatomy of schizophrenia (Apropos of a post-mortem examination)].
    Fiorentini H
    Med Leg Dommage Corpor; 1974; 7(2):155-7. PubMed ID: 4459676
    [No Abstract]   [Full Text] [Related]  

  • 17. Electrophysiological studies on the brain. Effects of nucleotide and tryptophan metabolites as modified by polyamines in normal and psychotic subjects.
    Cowen MA
    Dis Nerv Syst; 1970 Nov; 31(11):772-80. PubMed ID: 5489816
    [No Abstract]   [Full Text] [Related]  

  • 18. N-acetylaspartate (NAA) levels in selected areas of the brain in patients with chronic schizophrenia treated with typical and atypical neuroleptics: a proton magnetic resonance spectroscopy (1H MRS) study.
    Szulc A; Galińska B; Tarasów E; Kubas B; Dzienis W; Konarzewska B; Poplawska R; Tomczak AA; Czernikiewicz A; Walecki J
    Med Sci Monit; 2007 May; 13 Suppl 1():17-22. PubMed ID: 17507880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional alterations in RGS4 protein in schizophrenia.
    Erdely HA; Tamminga CA; Roberts RC; Vogel MW
    Synapse; 2006 Jun; 59(8):472-9. PubMed ID: 16565965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schizophrenia and the brain at the 1984 winter workshop, Davos, Switzerland.
    Stevens JR
    Arch Gen Psychiatry; 1984 Aug; 41(8):816-7. PubMed ID: 6742981
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.